🔎 Trials Near Me

Gara Jalqabaatti › Neuroblastoma

Qorannoo klinikaalii Neuroblastoma Ameerikaa Keessatti hirmaatuu

Qorannoo 47 Neuroblastoma f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.

Magaalota qorannoo baay'ee qaban

Naannoon

Qorannoo yeroo dhihootti haaromfaman

Takkalaa qorannoo (Ingiliffa)

Molecular Characterization of Neuroblastic Tumor: Correlation With Clinical Outcome

Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin hundi · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT00588068

A First-in-Human Phase I Trial With Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors, Carcinomas and Malignant Peripheral Nerve Sheath Tumors

Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 120 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT06041516

Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
4 Weeks · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT01109394

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Namoota walitti qabaa jiraSadarkaa 3
Hanga umuriin 30 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06172296

MCT for the Harvard/UCSF ROBIN Center

Namoota walitti qabaa jira
Umuriin hundi · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06000787

A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma

Namoota walitti qabaa jiraSadarkaa 2Hojjettoota fayyaa simatamoo
Umuriin hundi · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT04936529

Phase I Trial of rhIL-15 Plus Dinutuximab Plus Irinotecan/Temozolomide for Children and Young Adults With Relapsed/Refractory Neuroblastoma

Namoota walitti qabaa jiraSadarkaa 1
Umuriin 3 hanga 35 · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT06995872

Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms

Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 4 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT01005654

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

Namoota walitti qabaa jiraSadarkaa 1/2
6 Months – 25 Years · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT06395103

Biomarkers of Resiliency In Childhood Cancer Surgery

Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 3 hanga 25 · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT06674811

Pediatric Precision Laboratory Advanced Neuroblastoma Therapy

Namoota walitti qabaa jiraSadarkaa 2
Hanga umuriin 22 · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT02559778

Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas

Namoota walitti qabaa jiraSadarkaa 1/2
Hanga umuriin 26 · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT06465199

Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
Hanga umuriin 30 · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT06541262

B7-H3.CD28Z.CART in Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
9 Months – 30 Years · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT07358260

Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma

Namoota walitti qabaa jiraSadarkaa 2
Umuriin 1 hanga 21 · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT06540963

International Congenital Central Hypoventilation Syndrome (CCHS) Registry and CCHS SHARE

Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin hundi · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT03088020

N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma

Namoota walitti qabaa jiraSadarkaa 2
18 Months – 19 Years · Saalaa hunda · Haaromfame 28-Hag-2026 · NCT06528496

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

Namoota walitti qabaa jiraSadarkaa 3
365 Days – 30 Years · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT03126916

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
12 Months – 30 Years · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT04851119

Haploidentical Donor Cytokine-Induced Memory-Like Natural Killer Cells (CIML-NK) for Relapsed & Refractory Neuroblastoma

Namoota walitti qabaa jiraSadarkaa 2
Umuriin 1 hanga 39 · Saalaa hunda · Haaromfame 24-Hag-2026 · NCT07635056

Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE)

Namoota walitti qabaa jiraSadarkaa 1
Umuriin 1 hanga 23 · Saalaa hunda · Haaromfame 13-Hag-2026 · NCT07172958

Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma

Namoota walitti qabaa jiraSadarkaa 2
12 Months – 21 Years · Saalaa hunda · Haaromfame 12-Hag-2026 · NCT05489887

SPEARHEAD-3 Pediatric Study

Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 2 hanga 21 · Saalaa hunda · Haaromfame 11-Hag-2026 · NCT05642455

A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma

Namoota walitti qabaa jiraSadarkaa 2
Umuriin hundi · Saalaa hunda · Haaromfame 28-Ado-2026 · NCT06057948

PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 1 hanga 30 · Saalaa hunda · Haaromfame 22-Ado-2026 · NCT06721689

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.